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Abstract 
 
Melatonin is a vital natural neurohormone that regulates the daily circadian rhythm in 
mammals.  Melatonin is the most potent known antioxidant. At night the pineal gland’s 
output of Melatonin rises and the Melatonin is carried by the circulation system throughout 
the body, passing through the cell membrane and scavenging free radicals in the cell to 
project the DNA. It also has many other vital functions involving assistance of the immune 
system to maintain its immunocompetence, and it regulates slip activity including aspects 
of REM sleep and sleep efficiency. Hints substances of activity at reduced melatonin 
output causes many serious biological effects in humans and other mammals, including 
sleep disturbance, chronic fatigue, DNA damage leading to cancer, cardiac, reproductive 
and neurological diseases and mortality.  Reduced melatonin is also associated with 
arthritis, depression and suicide, seasonally affective disorder (SAD), miscarriage, sudden 
infant death syndrome (SIDS), Schizophrenia, Alzheimer’s disease and Parkinson’s 
disease. Multiple independent studies will have found that electromagnetic fields reduced 
melatonin in animals, flesh of and human beings. The evidence includes correlations with 
Geomagnetic Activity reducing human melatonin, through the Schumann Resonance 
signal effect. The level of evidence exceeds the usual requirement for causal link.  This 
strongly suggests that melatonin production caused by electromagnetic fields and 
radiation exposure contributes significantly to the allocation of many adverse health effect 
rates in the community. 
 
The Pineal Gland: 
 
The pineal gland, a pea-sized organ near the centre of the brain, converts serotonin into 
melatonin. This has a strong diurnal (daily) pattern, with high melatonin output at night and 
low melatonin output during the day. Alternatively, serotonin dominates the day and is 
lower at night. The Melatonin/Serotonin cycle is a primary physiological driver of the daily 
metabolic, awake/sleep cycle.  Melatonin is a vital part of many of the body’s biochemical 
systems, including sleep and learning and is free radical scavenging in all cells and hence 
is a potent antioxidant with anti-aging and anti-cancer properties. It helps to protect 
embryonic fetuses. Melatonin mediates many hormone functions, assists in maintaining 
immune system health and virus protection. 
 
The light-driven daily cycle is primarily controlled by signals from the retina of the eyes that 
mediate the pineal function though a flow of chemical messengers. Signal messengers 
from the retina arrive at the receptors on the surface of the pinealocytes. Through 
regulation of the cyclic AMP (cAMP) pathway, the serotonin/melatonin transformation is 
controlled. 
 
Confirmation of the electromagnetic sensitivity of the human pineal comes from 
therapeutic uses of picoTesla ELF fields in the successful treatment of a range of 
neurological diseases, Sandyk (1993, 1994), Sandyk and Derpapas (1993) and Sandyk 
and Iacono (1993). These studies specifically involve Parkinson's Disease and Multiple 
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Sclerosis. The authors identify the magneto-sensitivity of the pineal gland and the role of 
melatonin as the biological mechanism for this therapy. 
 
 
Figure 1: A schematic cross-section of the brain highlighting the pineal glad. 
 
A key element of the cAMP pathway is calcium ions. Substances that can alter cellular 
calcium ions act at many levels involving many cell receptors and cellular processes. 
Calcium ion efflux from the pinealocytes has the effect of reducing melatonin through 
reducing the cAMP, Figure 2. 
 
 
Figure 2: The biochemical mediation system for serotonin transformation to melatonin 
in the pinealocytes showing the signal transduction pathways from the retina 
to the cell and the cell receptor, through cyclic AMP and NAT to the 
transformation process, Reiter (1994). 
 
 3
 
EMR alters calcium ion homeostasis: 
 
Electromagnetic radiation across the spectrum alters calcium ion homeostasis in cells. 
The primary factor is the ELF modulation of the signal, Bawin and Adey (1976), Adey 
(1980). This occurs in a complex set of exposure windows. The efflux and influx for 
calcium ions also varies with ambient temperature, geomagnetic field strength and 
orientation, and signal intensity, Blackman et al. (1988, 1989, 1991).  Blackman (1990) 
concludes that this is an established biological mechanism. Blackman et al. (1991) 
showed that Ca2+ efflux occurred for tissue temperatures of 36°C and 37 °C and not at 
35°C and 38°C. They comment that these could be very good reasons why experimental 
outcomes have been difficult to confirm in some laboratories. This shows why high SAR 
exposures do not produce altered calcium ions because the rise in tissue temperature 
takes the tissue outside the homeostatic thermal range within which calcium ion 
efflux/influx occurs to regulate normal cell behaviour. 
 
The calcium ion efflux research demonstrates one of the fundamental principles of EMR 
research. Under given specific conditions the calcium ion efflux (positive or negative) does 
occur at some combination of exposure conditions, but not at a nearby slightly different set 
of conditions. This is because of the "window" non-linear nature of the effect with respect 
to modulation frequency and intensity in particular. Also, one set of conditions that 
produce a significant effect in one laboratory does not produce any observed effect in 
another laboratory because it has a different geomagnetic field.  On the other hand, in real 
world situations workers or residents are continually passing through effective and non-
effective windows of exposure. 
 
There are great difficulties of detecting melatonin reduction in people because of the large 
intra-personal differences from day to day, and the very large inter-personal differences. 
Despite this, on average there is a dominance of exposure conditions that do cause 
calcium ion efflux and reduced melatonin, so that it is observed to differ in most monitored 
populations in the real world. 
 
DNA strand breaks, Chromosome Aberrations, impaired immune system competence and 
many other biological and health effects, are caused by reduced melatonin, Reiter and 
Robinson (1995).  Light-at-night and electromagnetic radiation, are proven to reduce 
melatonin and hence pose significant adverse health effects. 
 
EMR Reduces Melatonin in Animals: 
 
Light-at-night and electromagnetic radiation, are proven to reduce melatonin and hence 
pose significant adverse health effects. The evidence for EMR is summarized here. 
Rosen, Barber and Lyle (1998) state that seven different laboratories have reported 
suppression of nighttime rise in pineal melatonin production in laboratory animals. They 
show that a 50 µT, 60 Hz field with a 0.06µT DC field, over 10 experiments, averages a 
46% reduction in melatonin production from pinealocytes. Yaga et al. (1993) showed that 
rat pineal response to ELF pulsed magnetic fields varied significantly during the light- 
dark-cycle. They found that the rate-limiting enzyme in melatonin synthesis, N-
acetyltransferase (NAT) activity showed that magnetic field exposure significantly 
suppressed NAT during the mid- to late dark phase. 
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 Stark et al. (1997) observed a significant increase in salival melatonin in a group of 5 
cows when the short-wave radio transmitter at Schwarzenberg, Switzerland, was turned 
off for three days, compared to 5 cows that had much lower RF exposure. Hence there are 
now at least ten independent observations of melatonin reduction in animals from ELF and 
RF exposure. 
 
EMR Reduces Melatonin in People 
 
Seventeen studies from show that ELF and RF/MW exposure reduces melatonin and 
enhances serotonin in people. Evidence that EMR reduced melatonin in human beings 
commenced with Wang (1989) who found that workers who were more highly exposed to 
RF/MW had a dose-response increase in serotonin, and hence indicates a dose-response 
reduction in melatonin. Sixteen studies have observed significant EMR associated 
melatonin reduction in humans. They involve a wide range of exposure situations. This 
includes 16.7 Hz fields, Pfluger et al. (1996); 50/60 Hz fields, Wilson et al. (1990), Graham 
et al. (1994), Wood et al. (1998), Karasek et al. (1998), Burch et al. (1997, 1998, 1999a, 
2000), Juutilainen et al. (2000) and Graham et al. (2000); combination of 60 Hz fields and 
cell phone use, Burch et al. (1997,1999a); VDTs ELF/RF exposures, Arnetz et al. (1996), 
and a combination of occupational 60Hz exposure and increased geomagnetic activity 
around 30nT, Burch et al. (1999b). Two recent studies recorded significant melatonin 
reduction in women in EMF residential exposure situations, Davis et al. (2002) and 
Levallois et al. (2002). 
   
The Davis (1997) study involved residential exposures and observed nocturnal reductions 
in melatonin metabolite, 6-OHMS. The author states that while the effect was small it 
occurred at milliGauss levels and followed a dose-response trend. The effect was 
strongest among women who were on medication that also reduces melatonin. They 
showed a significant dose-response trend, with a 2- , 3- and 4-fold increase in magnetic 
field resulting in 8%, 12 % and 15 % reductions in melatonin, respectively, Figure 4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Human melatonin reduction from residential field exposures, the horizontal graph 
scale is in multiples from the lowest exposure (1), Davis (1997). 
 
The eighteenth human melatonin reduction study is from 6.1-21.8 MHz SW RF exposure 
as reported during the shutting down process of the Schwarzenburg shortwave radio 
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tower, Professor Theo Abelin (seminar and pers.comm.). Urinary melatonin levels were 
monitored prior to and following the closing down of the Schwarzenburg short wave radio 
transmitter. This showed a significant rise in melatonin after the signal was turned off. 
 
Schumann Resonance-S/GMA melatonin reduction links: 
 
Cherry (2002) shows that it is extremely highly probable that the biophysical mechanism 
for the human health effects of correlated with Solar/Geomagnetic Activity is the 
Schumann Resonance signal, with a mean field strength of 0.1pW/cm2. Burch et al. 
(1999b) found that the strongest factor reducing melatonin in electrical workers, in addition 
to their occupational ELF and 3-phase exposures and cell phone usage, was the 
Geomagnetic Activity, in a dose-response manner, Figure 5. 
 
 
Figure 5: Reduction in the melatonin metabolite 6-OHMS in µg in urine from U.S. electric 
utility workers, as a function of the 36 hr global GMA aa-index, Burch et al. 
(1999b). 
 
Burch et al. (1999b) showed a probable causal link between the Schumann Resonance 
signal and reduced melatonin, Cherry (2002). In addition there is Weydahl et al. (2001) 
and Rapoport et al. (1997, 1998, 2001). Bardasano et al. (1989) observed an extremely 
significant reduction (p<0.001) in synaptic ribbons of pinealocytes of rats during 
geomagnetic storms compared with quiet solar days. Thyroxine levels in a single limbic 
epileptic patient were highly correlated (r = 0.66) in a dose-response manner, with daily 
GMA, O'Connor and Persinger (1996). The strongest association (r = 0.76) was found 
between thyroxine levels and the Kp index during the previous night (2 am to 5 am). 
These analyses were carried out specifically to test the GMA Melatonin mechanism and 
they support it. 
 
Hence it is established from multiple, independent studies, that EMR 
from ELF to RF/MW, including being extremely low intensity natural 
electromagnetic fields, reduces melatonin in animals and human 
beings. 
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The Health Implications of Reduced Melatonin: 
 
Melatonin has many biological effects. The melatonin receptor regulates several second 
messengers: cAMP, cGMP, diacylglycerol, inositol trisphosphate, arachidonic acid, and 
intracellular Ca 2+ concentration ([Ca2+]j).  In many cases, its effect is inhibitory and 
requires previous activation of the cell by a stimulatory agent.  Melatonin inhibits cAMP 
accumulation in most of the cells examined, but the indole effects on other messengers 
have been often observed only in one type of the cells or tissue, until now.  Melatonin also 
regulates the transcription factors, namely, phosphorylation of cAMP-responsive element 
binding protein and expression of c-Fos.  Molecular mechanisms of the melatonin effects 
are not clear but may involve at least two parallel transduction pathways, one inhibiting 
adenylyl cyclase and the other regulating phosphohpide metabolism and [Ca 2+]j, Vaneeck 
(1998).  
 
Professor Russell Reiter, one of the world's leading medical researchers into the effects 
of melatonin, summarizes melatonin’s roles, Reiter and Robinson (1995), as being: 
 
• Vital for healthy sleep, including lowering the body temperature, and assisting in 
maintaining health sleep states. 
 
• Reduces cholesterol, with consequent reductions is risk of atherosclerosis and 
coronary heart disease. 
 
• Reduces blood pressure and the tendency for blood clots, and hence reduces the risk 
of strokes. 
 
• Scavenger of free radicals.  This, along with the above factors, reduces the risk of 
heart attack, cancer, viral replication. Melatonin plays a vital free radical scavenging 
role in the brain where, because it is high in iron, has a high production rate of 
hydroxyl radicals (OH•).  Free radical damage is now known to play a formative role in 
most brain disorders, including Alzheimer’ disease, Lou Gehrig’s disease, multiple 
sclerosis and Parkinson’s disease.  While the Blood Brain Barrier (BBB) denies 
access to most free radical scavengers, melatonin has free access. 
 
• Enhances the effectiveness of the immune system. Specifically enhancing the T-cells, 
i.e. the T-helper cells and the T-killer cells.  T-helper cells have a receptor for 
melatonin.  When melatonin is received a cascade of events is set in motion including 
stimulation of Interleukin-4 (IL-4) which then stimulates natural killer cells (NK), B-
cells, IgA, phagocytes and T-Cytotoxic cells.  The NK cells specialize in attacking 
cancer cells and virus infected cells. 
 
In Professor Reiter’s book, published in 1995, he describes the evidence that EMR/EMF 
does reduce melatonin as a “Smoking Gun” level of proof. That is, there is considerable 
scientific evidence but at that time it wasn’t sufficient for scientific proof. By considering 
more recent information, and the extensive results of biometeorological research, and 
linking the melatonin research to the calcium ion research, the level of proof can be seen 
as causal. The multiple observations of melatonin reduction in EMR exposed populations 
means that EMR exposure increases the incidence of all of the conditions identified by 
Reiter and Robinson above, including impaired immune system, diseases from infections 
and viruses, arthritis, diabetes, cancer, reproductive, neurological and cardiac disease 
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and/or death. Epidemiological evidence of exposed workers and residential populations 
confirms all of these, except arthritis, have been identified to occur in EMR exposed 
human populations. 
 
Sleep disturbance as a melatonin reduction bioindicator: 
 
It is a well-established and brain is a sensitive either electromagnetic organ.  One of the 
most dominant activities is the daily awake/sleep cycle.  Melatonin is one of primary 
regulators of the cycle can regulate the sleep activity. Therefore one of the primary server 
and surname methods for a non-invasive melatonin tracker is sleep disturbance.  Because 
of the extensive vital rolls of melatonin in many serious health events, the identification of 
a simple and reliable indicator, such as sleep disturbance may be a simple way of 
indicating the product is dangerous because of its ability to reduce melatonin is indicated 
by sleep disturbance. 
 
Sleep Disturbance near a Shortwave Radio Tower, Schwarzenburg, Switzerland: 
 
The Schwarzenburg Study, Alpeter et al. (1995) and Abelin (1999) found a causal 
relationship of sleep disturbance with exposure to a short-wave radio signal. The effect is 
assessed as causal because of the significant dose-response relationship, the variation of 
sleep disturbance in two experiments, one involving changing the beams and one turning 
the transmitter off, and the identification of significant melatonin reduction. Professor 
Abelin told seminars in Christchurch that they had measured a significant increase in 
melatonin after the tower transmission was turned off permanently compared to the levels 
measured while it was on. 
 
Figure 6 shows the results of the two surveys of sleep disturbance from 1992 and 1996.  
The first survey was for three groups, A, B and C. For the second survey a third group 
requested involvement. Their exposure level was between zone B and zone C and their 
rate of sleep disturbance showed a consistency with the dose-response trends. 
 
 
Figure 6: Adult Sleep Disturbance with RF exposure at Schwarzenburg, Switzerland, 
Abelin (1999). 
 
 An extensive measurement survey was carried out and a mean exposure for each zone 
was determined.  These readings are used to create the dose-response graph in Figure 7.  
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Figure 7: Dose-response relationship for Sleep Disturbance at Schwarzenburg with 
exposure in nW/cm2. Note: 1nW/cm2= 0.001µW/cm2 
 
Groups B, R and C are all exposed to a mean RF signal of less than 0.1µW/cm2 and they 
experienced highly significant sleep disturbance and reduced melatonin. Sleep disruption 
occurs in a dose-response manner with a threshold below 0.1nW/cm2. i.e. very close to 
zero, Figure 7. 
 
In an experiment the tower was secretly turned off for three days reacts during which the 
sleep disturbance was being surveyed.  Each group showed a significant improvement in 
sleep quality and a time delay in reaction which increased with distance from the tower. 
Group A showed a 1 day delay and Group C a two day delay and both showed a highly 
significant improvement in sleep quality, p< 0.001. 
 
 
Figure 8: Sleep disturbance in people exposed to a short-wave radio stations which 
was turned off for three days, Altpeter et al. (1995), showing the highest 
exposed Group A, and lowest exposed Group C. 
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The lowest exposed group, 0.0004µW/cm2 (0.4nW/cm2), also shows a significant effect of 
the RF exposure on sleep disturbance confirming that they too have a significant sleep 
disturbance problem caused by the tower exposure, which was reduced when the tower 
was briefly turned off and occurred again when it was turned on again. 
 
Since sleep disturbance, Mann and Roschkle (1995), and melatonin reduction, Burch et 
al. (1997), has been observed with cell phone radiation exposure. Hence these 
observations also apply to cell phones and cell sites. An investigation of sleep disturbance 
and a large number of other neurological symptoms was investigated in France, Santini et 
al. (2001). They found significant elevation of sleep disturbance within 300m of cell sites.  
The pattern in Figure 9 is closely dose related to the typical cell site radial exposure 
patterns, Figure 10. 
 
 
Figure 9: Sleep disturbance in the vicinity of cell sites in France, Santini et al. (2001) 
 
Figure 10 shows a typical cell site exposure pattern along the main beam of the antenna.   
 
Figure 10: A typical cell site radial center main beam ground level (2m) radiation exposure. 
 
The actual mean residential exposures are somewhat less than this because the direct 
exposure is generally less than at the centre of the main beam and buildings provide 
significant reductions in exposure levels. Moving around the residential area also smooths 
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out the mean exposures somewhat. Table 1 shows the surveys incidence rates of many 
neurological symptoms. 
 
Table 1: Incidence of symptoms as a function of the distance from cellphone base stations 
by 530 people (men and women) as compared to people living more than 300 m 
for not exposed to base stations. 
 
Distances of subjects from cell phone base stations (m) 
< 10 m 10 to 50 m 50 to 100 m 100 to 200 m 200 to 300 m > 300 m … 
 
Symptoms 
2 3 2 3 2 3 2 3 2 3 2 3 
Fatigue 76 * 72 * 63.5* 50.9* 60.6 56.6* 64.2 41.1 66.6* 43.7 40.7 27.2 
Irritability 32.8 23.2* 41.7* 25.7* 47.2* 44.1* 25.8 4.1 25 9 18 3.3 
Headache 51 * 47.8* 40 * 26.1* 40.6* 36.7* 60.7* 31.2* 19.3 0 15.6 1.8 
Nausea 14.5* 6.9 8.4 3 5.7 3.8 2.4 4.6 0 2.3 2.1 1.1 
Loss of appetite 20.4* 8.3 8 5.5 5 5 6.9 0 4.2 0 3.3 3.3 
Sleep 
Disturbance 
41.3* 57.1* 41.4* 57.5* 46.9* 58.5* 45.8* 50* 33.3 35.5 13.8 21.1 
Depression 16.9 26.8* 21.6 19.7* 11.6 24 * 16.2 3.1 13.6 2.5 10.3 3.7 
Discomfort 28 * 45.4* 25.2* 18.9 30.6* 12.8 15.7* 0 9.7 5.1 2.4 8.1 
Difficulties in 
concentration 
39.3 28.8* 37.5 16.6 34.2 26.4* 25 12.5 43.3 5.5 26.7 7.1 
Loss of Memory 27.8 25.4* 29.4 26.6* 37.1* 29 * 25 15.6 17.2 11.1 17.9 5.8 
Cutaneous 
problems 
18.1* 17.1* 6.6 10.8 11.1* 11.1 13.9* 7.5 8.7 0 1.2 4.6 
Visual 
Perturbations 
14.5 24.3* 23 13.5 22 7.1 2.5 4.9 15 2.8 13.6 4.1 
Hearing 
Difficulties 
33.3* 17.4 17.7* 12 8.3 15.5 7.7 7.7 11.6 9.5 5.6 8.7 
Vertigo 10 12.5* 17.3* 7.5* 9.6 9.6* 12.2 2.7 7.7 5.2 6.2 0 
Moving 
Difficulties 
5.6 7.7* 8.2 1.7 3 3 0 0 2 0 2.9 1 
Cardiovascular 
Problems 
 
 
10.1* 
 
13 * 
 
15.3*
 
9.6 
 
12.3*
 
7.4 
 
8.7 
 
0 
 
8.5 
 
6.5 
 
1 
 
3 
* = Chi Squared test Significance (p < 0.05) for exposed subjects compared to those living more 
than 300m from a base station or not exposed.  2 = "often" and  3 = "very often" 
 
Every symptom has at least one significantly elevated incident rate.  Most of the 
symptoms are consistent with reduced melatonin. Several of the seriously elevated 
symptoms have been identified to increase in a dose-response manner of minutes/day 
usage of cell phones in Scandinavia, Mild et al. (1998). They include dizziness, 
discomfort, loss of concentration, memory loss, fatigue, headache and skin reactions of a 
burning feeling and tingling, Figure 11. 
 
Very strong evidence that sleep disturbance and melatonin reduction had already been 
associated with a wide range of residential exposure to cellphone radiation and user 
exposure to cellphone radiation.  This confirms the relationship and the usefulness of this 
and melatonin reduction based bioindicator of approach losing sleep disturbance as the 
first indicator, or any other melatonin action related health effect that is easy to assess all 
for which there is already a public database. 
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Figure 11: Prevalence of symptoms for Norwegian mobile phone users, mainly analogue, 
with various categories of length of calling time per day, Mild et al. (1998). 
 
Conclusions and Recommendations: 
 
There is substantial and robust evidence that establish a causal relationship between 
electromagnetic fields and radiation reduced melatonin.  Therefore there is a sound 
scientific basis for concluding that the melatonin mechanism is one of the established 
mechanisms between very serious health effects and acute and chronic exposure to 
electromagnetic fields and radiation. The natural signal, the Schumann Resonance signal, 
has a radio field intensity of about 0.1pW/cm2 and sleep disturbance was highly correlated 
(p<0.001) with exposure to the shortwave radio signal measured at 0.4nW/cm2. Because 
sleep disturbance and melatonin reduction are causally linked to many other serious 
health effects, a public protection standard to reduce the incidence of these health effects 
would need to be somewhat less than 0.1nW/cm2. 
 
Because of the extreme sensitivity of the brain electromagnetic fields and radiation and 
the reaction of reduced melatonin, a melatonin based bioindicator mechanism, such as 
sleep disturbance, can be a very useful tool or showing that electromagnetic signal is 
causing many other serious health effects, including all of which are linked with reduced 
melatonin. 
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